K 03122 4
MAY - 9 2003 510(K) Summary
Submitter: Cynosure, Inc.
10 Elizabeth Drive
Chelmsford, MA 01824
Contact: George Cho ,
Senior Vice President of Medical Technology

Date Summary Prepared: April 16, 2003

Device Trade Name: Smart CO,

Common Name: Medical Laser System

Classification Name: Instrument, surgical, powered, laser
79-GEX
21 CFR 878.4810

Equivalent Device: PhotoAppeal laser

Device Description: Smart CO, is a CO, laser, having a sealed CO, gas tube as the lasing :
medium. It is a laser with a wavelength of 10.6 pm.

Laser activation is by foot switch. Overall weight of the laser is 25
Kg, and the size is 180x62x42 cm (HxWxD).
Electrical requirement is 110 VAC, 15A, 50-60 Hz, single phase.

Intended Use: The Smart CO, laser is indicated for incision, excision, and
coagulation of body soft tissue.

Comparison: The Smart CO, laser is substantially equivalent to the PhotoAppeal
laser, with the same principle of operation, the same wavelength and
essentially the same power range as the predicate devices for the same
indications for uses.

Nonclinical Performance Data: none

Clinical Performance Data: none

Conclusion: The Smart CO, laser is another safe and effective device for body soft
tissue applications.

Additional Information: none

en,
f ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Heaith Service
a
Food and Drug Administration
Rockville MD. 20850
MAY ~ 9 2003
Mr. George Cho :
Senior Vice President of Medical Technology
Cynosure, Inc.
10 Elizabeth Drive
Chelmsford, Massachusetts 01824
Re: K031224
Trade/Device Name: Smart CO, Laser
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: April 16, 2003
Received: April 23, 2003
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class IIT (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 -~ Mr. George Cho
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the
promotion and advertising of your device, please contact the Office of Compliance at (301) 5944639. Also, please note the regulation entitled, "Misbranding by reference to premarket
notification” (21CFR Part 807.97) you may obtain. Other general information on your
responsibilities under the Act may be obtained from the Division of Small Manufacturers,
International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597
or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Yuduamn 0. Proves

for Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
/ Radiological Health

Enclosure

useearcuug LoTUZ drezobUdby PAGE 63/68
$10(k) Number (if known): 03 [a2
Device Name: Smart CO, (Smart US 20D, Smart Clinic) Laser
Indications For Use:

The Smart CO, surgical lasers are indicated for incision, excision, and coagulation of body soft
tissuc. It's typical applications include dermatology, plastic surgery, urology, gastroenterology,
neurosurgery, gynecology and general surgery.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) ~
LC Frovent
(Division Sign-Off) .
Division of General, Restorative
and Neurologic! .-eviees
510(k) Number _KO3/224
Prescription Use, x OR Over-The-Counter Use,
(Optional Format 1-2-96)

